Mount Sinai Fuster Heart: Topics in Cardiology

Wednesday, May 15, 2024, 6:30 PM - 10:00 PM, Portofino Ristorante, 109-32 Ascan Avenue, Queens, NY, Forest Hills, NY


The event will consist of 3 presentations about cardiovascular topics pertinent to primary care physicians and will include a question and answer session after each.

Presentations:
1. An approach to the diagnosis and management of the swollen leg for the primary care physician
2. Preventing the development of heart failure in patients at risk: what the primary care provider needs to know
3. Renal denervation: a new tool in the armamentarium for treating resistant hypertension

1. Describe an approach to the diagnosis of the various causes of leg swelling including appropriate imaging and consult
2. Discuss the role of renal denervation in the management of refractory hypertension and to be able to offer that option to appropriate patients
3. Identify an approach to the patient at risk for developing heart failure and understand measures that can be taken to mitigate those risks

Registration is complimentary.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Attendance (2.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. Relevant financial relationships will be mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Wednesday, May 15, 2024